We are proud to have been part of the almost five year long Prospective Country Evaluations (PCE) (2017-2021), funded by the Global Fund.
Eight countries were part of the project with Euro Health Group implementing activities in Cambodia, Mozambique, Myanmar and Sudan. Over the four and a half years we worked closely in partnership with Itad (UK) and UCSF (US); with our four country evaluation partners Angkor Research and Consulting (Cambodia), Instituto Nacional de Saúde (Mozambique), Myanmar Knowledge Management Foundation (Myanmar), and Blue Nile Institute for Communicable Diseases (Sudan) – as well as IHME and Path, the consortium implementing the project for the other four countries (DRC, Guatemala, Senegal, Uganda). The overarching aim of the PCE was to generate evidence from ongoing country programmes with the aim of accelerating progress towards the achievement of the Global Fund’s Strategic Objectives (1-4) and Strategic Enablers of the 2017-2022 Strategy “Investing to End Epidemics”.
The PCE was an ambitious evaluation, tracking – in real time – Global Fund grant implementation at the country level. The evidence and findings gathered in the country evaluations were used to strengthen and/or cause corrections in national disease programming, as well as provide valuable insights into how the Global Fund business model and the 2017-2022 Strategy,” Investing to end epidemics”, played out in PCE countries.
The four synthesis reports for all eight PCE countries, including the synthesis report for the last half year, rounding off the whole programme can be found on The Global Fund web here.